April 14, 2020 / Sergei Klebnikov, Forbes Staff TOPLINE – Shares of pharmaceutical and consumer goods giant Johnson & Johnson jumped on Tuesday after the company raised its dividend—even after lowering its forecast for the rest of the year—and beat revenue and profit estimates thanks to higher demand during the coronavirus pandemic. KEY FACTS The …